Former Premier League goalkeeper Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom. The 56-year-old was diagnosed with the ...

A new three-phase screening protocol that incorporates a PSA test, a four-kallikrein panel, and an MRI scan appears to improve the prostate cancer detection rate among men invited to participate in a ...

Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe. A large randomized trial conducted at Tampere University and ...

Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

This study investigated the outcomes of perioperative multidisciplinary nursing collaboration for patients who underwent laparoscopic radical prostatectomy.

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Jan. 9 (UPI) --Defense Secretary Lloyd Austin is in treatment for prostate cancer and recently underwent surgery, Walter Reed National Military Medical Center said in a statement on Tuesday. A ...

A large randomized trial shows that a new three-step prostate cancer screening method can find a considerable number of aggressive cancers. Population-level screening programs have not been launched ...